Bafnapharm Q2 Results

  • BSE: 532989
  • NSE: BAFNAPH
  • ISIN: INE878I01022
  • Sector: Biotechnology & Drugs
BSE
81.741.74 (2.18%)
Volume51.00
Updated: Mon 25 Nov, 2024 | 15:17:01
NSE
800.00 (0.00%)
Volume137.00
Updated: Mon 25 Nov, 2024 | 15:17:10
Today: 80.10
81.74
52-Wk: 73.35
112.20

Q2 Results Highlights

  • Total Income
    ₹40.32 Cr.
    (21.14%)
  • Operating Profit
    ₹2.22 Cr.
    (NA%)
  • Profit After Tax
    ₹2.62 Cr.
    (NA%)
  • Operating Margin
    5.50%
    (-19.02%)
Note: Comparison is on YoY basis

Quarterly - Bafnapharm Q2 Results

*All figures in crores except per share values
Fiscal PeriodSep 24Jun 23QoQ CompSep 23YoY Comp
Total Revenue 40.3241.95-%40.68-%
Selling/ General/ Admin Expenses Total 5.064.27-%4.85-%
Depreciation/ Amortization 1.571.21-%1.24-%
Other Operating Expenses Total 3.724.80-%3.03-%
Total Operating Expense 38.1136.86-%37.92-%
Operating Income 2.225.08-%2.76-%
Net Income Before Taxes 2.626.35-%2.48-%
Net Income 2.626.35-%2.48-%
Diluted Normalized EPS 1.112.68-%1.05-%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumInstant LoanMint Shorts